Atlas Trials

Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome

Clinical trial NCT06801249 · RECRUITING

Trial details

NCT number
NCT06801249
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Adrenal IncidentalomasCushing Syndrome
Start date
2021-02-23
Primary completion
2024-11-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.